Insider Transactions Reported by 18 Insiders of Definium Therapeutics, Inc.

Symbol
DFTX on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Definium Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stephen L. Hurst Director, Former Director $47,645,650 05 Jan 2022
Robert Barrow Chief Executive Officer, Director $14,708,826 -$914,189 -5.9% 03 Feb 2026
Daniel Karlin Chief Medical Officer $7,699,699 -$248,332 -3.1% 03 Feb 2026
Mark Sullivan Chief Legal Officer $5,457,524 -$380,892 -6.5% 03 Feb 2026
Schond L. Greenway Chief Financial Officer $2,064,137 25 Mar 2024
Brandi Roberts Chief Financial Officer $2,008,530 03 Feb 2026
Wiley Matthew T. Chief Commercial Officer $1,539,873 03 Feb 2026
Cynthia W. Hu Chief Legal Officer&Secretary $1,404,000 24 Mar 2022
Wernli Miri Halperin Executive President $1,248,839 21 Aug 2024
Carrie Liao Chief Accounting Officer $976,781 -$15,819 -1.6% 25 Mar 2025
Brigid Makes Director $185,686 01 Jun 2022
David W. Gryska Director $142,332 12 Jun 2025
Roger Adsett Director 29 Jan 2026
Sarah Y. Vinson Director 01 Jan 2022
Roger Crystal Director 12 Jun 2025
Suzanne Louise Bruhn Director 12 Jun 2025
Carol A. Vallone Director 12 Jun 2025
Andreas Krebs Director 12 Jun 2025

Recent Insider Transactions by Companies or Individuals for Definium Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Daniel Karlin DFTX Common Shares Award 35.3% 150,000 575,025 03 Feb 2026 Direct
Robert Barrow DFTX Common Shares Award 41.1% 320,000 1,098,477 03 Feb 2026 Direct
Wiley Matthew T. DFTX Common Shares Award 115,000 115,000 03 Feb 2026 Direct
Brandi Roberts DFTX Common Shares Award 150,000 150,000 03 Feb 2026 Direct
Mark Sullivan DFTX Common Shares Award 44.2% 125,000 407,576 03 Feb 2026 Direct
Roger Adsett DFTX Stock Option (Right to Buy) Award 50,000 50,000 29 Jan 2026 Direct
Daniel Karlin MNMD Common Shares Sale -1.3% $73,623 $13.15 -5,600 425,025 26 Dec 2025 Direct
Robert Barrow MNMD Common Shares Sale -3.21% $339,072 $13.15 -25,791 778,477 26 Dec 2025 Direct
Mark Sullivan MNMD Common Shares Sale -3.84% $148,244 $13.15 -11,276 282,576 26 Dec 2025 Direct
Mark Sullivan MNMD Common Shares Sale -3.7% $110,186 $9.77 -11,278 293,852 25 Sep 2025 Direct
Robert Barrow MNMD Common Shares Sale -3.11% $252,037 $9.77 -25,797 804,268 25 Sep 2025 Direct
Daniel Karlin MNMD Common Shares Sale -1.76% $75,268 $9.77 -7,704 430,625 25 Sep 2025 Direct
Mark Sullivan MNMD Common Shares Sale -3.63% $78,139 $6.80 -11,491 305,130 25 Jun 2025 Direct
Daniel Karlin MNMD Common Shares Sale -1.76% $53,366 $6.80 -7,848 438,329 25 Jun 2025 Direct
Robert Barrow MNMD Common Shares Sale -3.09% $180,139 $6.80 -26,491 830,065 25 Jun 2025 Direct
Andreas Krebs MNMD Stock Option (Right to Buy) Award 75,187 75,187 12 Jun 2025 Direct
Carol A. Vallone MNMD Stock Option (Right to Buy) Award 75,187 75,187 12 Jun 2025 Direct
Suzanne Louise Bruhn MNMD Stock Option (Right to Buy) Award 75,187 75,187 12 Jun 2025 Direct
Roger Crystal MNMD Stock Option (Right to Buy) Award 75,187 75,187 12 Jun 2025 Direct
David W. Gryska MNMD Stock Option (Right to Buy) Award 75,187 75,187 12 Jun 2025 Direct
Brandi Roberts MNMD Stock Option (Right to Buy) Award 500,000 500,000 02 Jun 2025 Direct
Robert Barrow MNMD Common Shares Sale -2.42% $142,942 $6.74 -21,208 856,556 25 Mar 2025 Direct
Daniel Karlin MNMD Common Shares Sale -1.51% $46,075 $6.74 -6,836 446,177 25 Mar 2025 Direct
Mark Sullivan MNMD Common Shares Sale -2.03% $44,322 $6.74 -6,576 316,621 25 Mar 2025 Direct
Carrie Liao MNMD Common Shares Sale -1.59% $15,819 $6.74 -2,347 144,923 25 Mar 2025 Direct
Wiley Matthew T. MNMD Stock Option (Right to Buy) Award 350,000 350,000 17 Mar 2025 Direct
Robert Barrow MNMD Common Shares Award 66.3% 350,000 877,764 12 Mar 2025 Direct
Daniel Karlin MNMD Common Shares Award 34% 115,000 453,013 12 Mar 2025 Direct
Mark Sullivan MNMD Common Shares Award 86.6% 150,000 323,197 12 Mar 2025 Direct
Carrie Liao MNMD Common Shares Award 54.2% 50,000 142,270 12 Mar 2025 Direct
Robert Barrow MNMD Common Shares Sale -3.5% $141,958 $7.43 -19,106 526,666 26 Dec 2024 Direct
Carrie Liao MNMD Common Shares Sale -2.28% $16,888 $7.43 -2,273 97,270 26 Dec 2024 Direct
Dan Karlin MNMD Common Shares Sale -1.93% $49,357 $7.43 -6,643 338,013 26 Dec 2024 Direct
Mark Sullivan MNMD Common Shares Sale -2.54% $33,576 $7.43 -4,519 173,197 26 Dec 2024 Direct
David W. Gryska MNMD Common Shares Purchase 14.4% $17,925 $7.17 2,500 19,851 05 Dec 2024 Direct
Carrie Liao MNMD Common Shares Sale -2.31% $14,065 $5.98 -2,352 99,543 25 Sep 2024 Direct
Robert Barrow MNMD Common Shares Sale -3.5% $118,231 $5.98 -19,771 545,772 25 Sep 2024 Direct
Dan Karlin MNMD Common Shares Sale -1.95% $41,089 $5.98 -6,871 344,656 25 Sep 2024 Direct
Mark Sullivan MNMD Common Shares Sale -2.43% $26,491 $5.98 -4,430 177,716 25 Sep 2024 Direct
David W. Gryska MNMD Common Shares Purchase 25.3% $20,930 $5.98 3,500 17,351 23 Aug 2024 Direct
Wernli Miri Halperin MNMD Common Shares Tax liability -13.9% -32,595 202,405 21 Aug 2024 Direct
Wernli Miri Halperin MNMD Common Shares Options Exercise 27% 50,000 235,000 21 Aug 2024 Direct
Wernli Miri Halperin MNMD Stock Option (Right to Buy) Options Exercise -100% -50,000 0 21 Aug 2024 Direct
Robert Barrow MNMD Common Shares Purchase 0.09% $3,060 $6.12 500 565,543 20 Aug 2024 Direct
Robert Barrow MNMD Common Shares Purchase 0.09% $3,155 $6.31 500 565,043 19 Aug 2024 Direct
Dan Karlin MNMD Common Shares Sale -1.93% $49,998 $7.22 -6,925 351,527 25 Jun 2024 Direct
Mark Sullivan MNMD Common Shares Sale -8.93% $128,906 $7.22 -17,854 182,146 25 Jun 2024 Direct
Robert Barrow MNMD Common Shares Sale -2.7% $113,058 $7.22 -15,659 564,543 25 Jun 2024 Direct
Carol A. Vallone MNMD Stock Option (Right to Buy) Award 16,506 16,506 10 Jun 2024 Direct
David W. Gryska MNMD Stock Option (Right to Buy) Award 16,506 16,506 10 Jun 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.